Back to top
ಭಾಷೆ ಬದಲಾಯಿಸಿ
SMS ಕಳುಹಿಸಿ ವಿಚಾರಣೆಯನ್ನು ಕಳುಹಿಸಿ

MOQ : 1 Vial

Specification

  • ಡ್ರಗ್ ವಿಧ
  • ಪದಾರ್ಥಗಳು
  • FERRIC CARBOXYMALTOSE
  • ಶಾರೀರಿಕ ರೂಪ
  • ಕಾರ್ಯ
  • ಇದಕ್ಕಾಗಿ ಶಿಫಾರಸು ಮಾಡಲಾಗಿದೆ
  • ANEMIA TREATMENT
  • ಡೋಸೇಜ್
  • AS DIRECTED BY THE PHYSICIAN
  • ಡೋಸೇಜ್ ಮಾರ್ಗಸೂಚಿಗಳು
  • The dose depends on your body weight and the cause of your anemia
  • ಪ್ರಮಾಣ
  • ಪೆಟ್ಟಿಗೆಗಳ
  • ಶೇಖರಣಾ ಸೂಚನೆಗಳು
  • Store below 25°C
 

Trade Information

  • Minimum Order Quantity
  • 1 Vial
  • ಮೋಸಮಾಡು ಪೋರ್ಟ್
  • BANGALORE
  • ಪಾವತಿ ನಿಯಮಗಳು
  • , , , , , , ,
  • ಪೂರೈಕೆ ಸಾಮರ್ಥ್ಯ
  • ವಾರಕ್ಕೆ
  • ವಿತರಣಾ ಸಮಯ
  • ದಿನಗಳು
  • ಮಾದರಿ ಲಭ್ಯವಿದೆ
  • Yes
  • ಮಾದರಿ ನೀತಿ
  • ಪ್ಯಾಕೇಜಿಂಗ್ ವಿವರಗಳು
  • STANDARD PACKING WITH GOOD SAFETY MEASURES
  • ಮುಖ್ಯ ರಫ್ತು ಮಾರುಕಟ್ಟೆ (ಗಳು)
  • ಮುಖ್ಯ ದೇಶೀಯ ಮಾರುಕಟ್ಟೆ
  • ಪ್ರಮಾಣೀಕರಣಗಳು
  • N/A
 

About

OROFER FCM contains Ferric carboxymaltose which belongs to the group of medicines called Iron replacement medicines. It is used to treat iron deficiency anaemia (IDA) in adults and in children (above 14 years of age), who are unable to take iron supplements orally, have an intolerance to oral iron supplements, need a rapid iron supplement in the body, have non-dialysis dependent chronic kidney disease. Iron deficiency anaemia is a condition in which the body lacks enough amount of iron, which is essential for the production of red blood cells and transport of oxygen in the body.

Your doctor may advise you to take relevant tests to understand your existing condition. Before receiving OROFER FCM inform your doctor if you are pregnant or planning to get pregnant or breast-feeding. OROFER FCM is not recommended for use in children and adolescents (under 14 years of age) and it should be used with caution in elderly patients (aged 65 years or above). Consult your doctor before receiving OROFER FCM.

The most common side effects of receiving OROFER FCM may include headache, dizziness, flushing, high blood pressure, nausea and injection or infusion site reactions. Consult your physician if any of the symptom worsens.        

USES OF OROFER FCM

Treats iron deficiency anaemia   

HOW OROFER FCM WORKS

OROFER FCM contains iron (III) hydroxide complexed with a carbohydrate polymer called carboxymaltose, which is capable of releasing iron. The iron released from the complex helps in the synthesis of haemoglobin and increases red blood cell count. As a result, it treats iron deficiency anaemia.     

DIRECTIONS FOR USE

OROFER FCM will be given to you only by a doctor or a nurse into a vein as an intravenous injection or infusion. Your physician will decide the correct dose and duration for you depending upon your age, body weight and severity of the condition.

SIDE EFFECTS OF OROFER FCM

COMMON

  • Headache
  • Dizziness
  • Flushing
  • High blood pressure
  • Nausea
  • Injection/infusion site reactions
  • Low levels of phosphorous in the blood

UNCOMMON

  • Numbness
  • Prickling or tingling sensation of the skin
  • Change in taste sensation
  • Increased heart rate
  • Low blood pressure
  • Difficulty in breathing
  • Vomiting
  • Indigestion
  • Stomach pain
  • Constipation
  • Diarrhoea
  • Itching
  • Redness of the skin
  • Skin rash
  • Muscle or joint pain
  • Back pain
  • Pain in the arms or the legs
  • Muscle spasms
  • Fever
  • Tiredness
  • Chest pain
  • Swelling of the hands and feet, and chills

RARE

  • Inflammation of the vein
  • General feeling of discomfort
  • Anxiety
  • Fainting or feeling faint
  • Wheezing
  • Flatulence
  • Rapid swelling of the face, mouth, tongue or throat which may cause difficulty in breathing
  • Paleness and discoloration of the skin in other areas of the body than the injected site

Contact your doctor immediately if you experience any of the following side effects:

  • Symptoms of serious allergic reaction or kounis syndrome (such as rashes, itching, swelling of the face, lips, mouth, tongue, throat or body causing difficulty in breathing or wheezing and chest pain)
  • Severe or life-threatening allergic reactions called anaphylactic reactions which can be associated with heart, circulation problems (low blood pressure) and loss of consciousness
  • Sign of a decrease in blood phosphorus causing softening of bones (osteomalacia) symptoms include worsening of tiredness, muscle or bone pain (pain in arms or legs, joints or back) and may lead to fractures
  • Signs of high blood pressure (such as facial flushing, dizziness or nausea)
  • Skin irritation and brownish discolouration of the skin at the injected site

HOW TO MANAGE SIDE EFFECT

Headache:

Take rest and relax. Drink plenty of fluids such as water. Apply a pain-relieving balm on the forehead if necessary. Consult your doctor if your headache does not improve.

Nausea or vomiting:

Stick to simple meals. Avoid eating oily, fried or spicy foods. Do not lie down or sleep immediately after eating. Consult your doctor if the symptom does not improve.

Stomach pain:

Try to take rest and relax. Eat and drink slowly or try to have smaller and frequent meals. Keep a heat pad on your stomach. If the symptom does not improve, consult your doctor.

Diarrhoea:

Drink lot of fluids, such as water or fruit juices to keep yourself hydrated. Avoid eating high-fat or spicy foods. If the symptom does not improve, consult your doctor.

Constipation:

Take fiber rich foods in your diet such as fresh fruits, vegetables and whole grain cereals, and drink plenty of fluids. Consult your doctor if the symptom does not improve.

WARNING & PRECAUTIONS

PREGNANCY

OROFER FCM should be used with caution in pregnant women only if considered clearly necessary. Inform your doctor if you are pregnant, think you may be pregnant, or planning to have a baby. Consult your doctor before receiving OROFER FCM.      

BREASTFEEDING

If you are breastfeeding, consult your doctor for advice before receiving OROFER FCM. It is unlikely that OROFER FCM represents a risk to the breast-fed child.   

DRIVING AND USING MACHINES

OROFER FCM is unlikely to impair the ability to drive or operate machines.

KIDNEY

OROFER FCM should be used with caution in patients with chronic kidney disease who are dependent of haemodialysis treatment. Consult your doctor before receiving OROFER FCM.  

LIVER

OROFER FCM should be used with caution in patients with liver disease. Consult your doctor before receiving OROFER FCM.                     

ALLERGY

Do not receive OROFER FCM if you are allergic to ferric carboxymaltose or any of the other ingredients of this medicine or if you have experienced serious allergic reactions to other injectable iron preparations.   

LUNGS

OROFER FCM should be used with caution in patients with severe asthma. Consult your doctor before receiving OROFER FCM.

OTHERS

OROFER FCM is not recommended for use if you have:

  • Anaemia not caused by iron deficiency
  • Iron overload (too much iron in your body) or disturbances in the utilisation of iron

Before receiving OROFER FCM inform your doctor if you have:

  • Systemic lupus erythematosus
  • Rheumatoid arthritis
  • Eczema or other allergies
  • An infection
  • Low levels of phosphate in the blood
  • High blood pressure

Use in paediatrics:

OROFER FCM is not recommended for use in children (under 14 years of age). Consult childs doctor for advice to treat the condition.

Use in geriatrics:

OROFER FCM should be used with caution in elderly patients (aged 65 years or above). Consult your doctor before receiving OROFER FCM.



How OROFER FCM INJ Works

OROFER FCM INJ contains ferric carboxymaltose, a compound that rapidly replenishes depleted iron stores in the body. By restoring adequate iron levels, it boosts hemoglobin production and improves oxygen transport in the blood, effectively combating symptoms of anemia and enhancing overall vitality.


Usage and Dosage Guidelines

The injection should be administered under medical supervision. Dosage and frequency depend on your specific body weight and the cause of anemia. Your healthcare professional will decide the correct dose, ensuring optimal results and minimizing risk. Never self-administer this medication.


Proper Storage Instructions

To retain its potency and safety, OROFER FCM INJ must be stored below 25C. Avoid exposure to direct sunlight and keep the injection away from children. Failure to store it correctly may impact its effectiveness or increase the risk of adverse reactions.

FAQs of OROFER FCM INJ:


Q: How should OROFER FCM INJ be used for anemia treatment?

A: OROFER FCM INJ should be administered as an injection by a healthcare professional, strictly following your doctors recommendations regarding dose and frequency.

Q: What is the main benefit of using OROFER FCM INJ?

A: The primary benefit is rapid replenishment of iron levels, which helps restore healthy blood supply and alleviates symptoms of anemia, such as fatigue and weakness.

Q: When should I take OROFER FCM INJ during my treatment?

A: This injection is given as per your physicians schedule, which is tailored to your iron levels, body weight, and the underlying cause of your anemia. Never self-administer or alter the schedule without consulting your doctor.

Q: Where should OROFER FCM INJ be stored to ensure safety and effectiveness?

A: Store OROFER FCM INJ in a cool, dry place below 25C, away from direct sunlight and out of reach of children, to maintain its effectiveness.

Q: What is the process for determining the correct dosage of OROFER FCM INJ?

A: Your doctor will evaluate your body weight and the specific cause of your anemia before prescribing the appropriate dosage. This personalized approach ensures safety and maximized benefit.

Q: Who is OROFER FCM INJ recommended for?

A: OROFER FCM INJ is recommended for individuals diagnosed with anemia who require prompt restoration of iron levels, as advised by their physician.

Tell us about your requirement
product

Price:  

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
ಮೊಬೈಲ್ number

Email

ಇನ್ನಷ್ಟು Products in speciality injections Category

INRONX 500 INJ

ಬೆಲೆಯ ಘಟಕ : Vial/Vials

ಶಾರೀರಿಕ ರೂಪ : Liquid

ಶೇಖರಣಾ ಸೂಚನೆಗಳು : Store below 25°C

ಕನಿಷ್ಠ ಆದೇಶ ಪ್ರಮಾಣ : 1

ಪದಾರ್ಥಗಳು : FERRIC CARBOXYMALTOSE

ಪ್ರಮಾಣ : ಪೆಟ್ಟಿಗೆಗಳ

RENOCEL 10000 IU INJ

ಬೆಲೆಯ ಘಟಕ : ತುಂಡು/ತುಂಡುs

ಶಾರೀರಿಕ ರೂಪ : Liquid

ಶೇಖರಣಾ ಸೂಚನೆಗಳು : Store in a refrigerator (2 8°C). Do not freeze.

ಕನಿಷ್ಠ ಆದೇಶ ಪ್ರಮಾಣ : 1

ಪದಾರ್ಥಗಳು : Epoetin Alfa

ಪ್ರಮಾಣ : ಪೆಟ್ಟಿಗೆಗಳ

REVTER INJ

ಬೆಲೆಯ ಘಟಕ : Vial/Vials

ಶಾರೀರಿಕ ರೂಪ : Liquid

ಶೇಖರಣಾ ಸೂಚನೆಗಳು : Store in a refrigerator (2 8°C). Do not freeze.

ಕನಿಷ್ಠ ಆದೇಶ ಪ್ರಮಾಣ : 1

ಪದಾರ್ಥಗಳು : TERLIPRESSIN

ಪ್ರಮಾಣ : ಪೀಸಸ್

INTACEPT 50MG INJ

ಬೆಲೆಯ ಘಟಕ : ತುಂಡು/ತುಂಡುs

ಶಾರೀರಿಕ ರೂಪ : Liquid

ಶೇಖರಣಾ ಸೂಚನೆಗಳು : Store in a refrigerator (2 8°C). Do not freeze.

ಕನಿಷ್ಠ ಆದೇಶ ಪ್ರಮಾಣ : 1

ಪದಾರ್ಥಗಳು : Etanercept

ಪ್ರಮಾಣ : ಪೆಟ್ಟಿಗೆಗಳ



ಸೂರ್ಯ ಸ್ಪೆಷಾಲಿಟಿ ಫಾರ್ಮಾ
GST : 29AXZPT5360J1ZC
Bno No - 33, ನೆಲ ಮಹಡಿ, 14ನೇ ಮುಖ್ಯ ಕುಮಾರಸ್ವಾಮಿ ಲೇಔಟ್, 1 ಸ್ಟ ಹಂತ,ಬೆಂಗಳೂರು - 560078, ಕರ್ನಾಟಕ, ಭಾರತ
ದೂರವಾಣಿ :08045804285
ಶ್ರೀ ಸುರೇಶ್ (ಮಾಲೀಕ)
ಮೊಬೈಲ್ :08045804285